-transparent.png){kind=logo}
In some individuals, chronic lymphocytic leukemia (CLL) may be associated with glomerular disease from membranous nephropathy with resultant nephrotic syndrome. CLL is characterized by abnormal immunoregulation with a malignant clonal proliferation of lymphocytes. The association between the abnormal clone and nephrotic syndrome is suggested in some cases by the remission of proteinuria with a reduction in abnormal lymphocyte number after treatment with antineoplastic agents. For the first time, we describe a patient with CLL and associated membranous glomerulopathy whose nephrotic syndrome remitted after treatment with fludarabine, a new purine analogue used in the treatment of refractory CLL.
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
January 2013,
Renal failure,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
January 1993,
Blood,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
January 2009,
Nature clinical practice. Nephrology,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
November 2022,
Kidney international reports,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
April 2001,
The New England journal of medicine,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
April 2001,
The New England journal of medicine,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
April 2001,
The New England journal of medicine,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
April 2001,
The New England journal of medicine,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
January 2000,
American journal of nephrology,
H Butty, and
J Asfoura, and
F Cortese, and
M Doyle, and
G Rutecki
January 2022,
Nefrologia,
